Novarad's VisAR receives Indonesian FDA clearance for AR surgical navigation

Medical technology company Novarad, has received Indonesian FDA clearance for VisAR, a surgical navigation system using augmented reality for intraoperative use in stereotactic spinal surgery. 

The technology allows surgeons to convert a patient's imaging data into a 3D hologram, which can be projected onto the patient's body with extreme precision. The technology allows for surgeons to concentrate on the surgical objective, rather than requiring them to look at a separate monitor. 

The system offers solutions in pre-surgical planning, virtual annotations, segmentation, and two-way image connectivity, as well as integrated 2D and 3D immersive navigation views and ongoing hologram-to-patient registration. The technology utilises CT fiducial markers visible in medical images for automatic registration.

Novarad has collaborated with Microsoft, utilising their pre-built AR technology, with VisAR, surgeons wear the wireless Microsoft HoloLens 2 visor, and have no need for other navigational equipment. 

VisAR is currently available in the U.S and now available in Indonesia, with expansion into other geographies expected in the future.